Education
About Us
Working with TipRanks
Follow Us
GeneTether Therapeutics, Inc. (TSE:RIZE)
:RIZE
RESEARCH TOOLSreports
RIZE Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.02 - $0.18
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
$2.27M
Enterprise ValueN/A
Total Cash (Recent Filing)$966.11K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.38
Next Earnings
May 22, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding75,744,675
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
GeneTether Therapeutics, Inc. News
RIZE FAQ
What was GeneTether Therapeutics, Inc.’s price range in the past 12 months?
GeneTether Therapeutics, Inc. lowest stock price was $0.01 and its highest was $0.18 in the past 12 months.
What is GeneTether Therapeutics, Inc.’s market cap?
GeneTether Therapeutics, Inc.’s market cap is $2.27M.
When is GeneTether Therapeutics, Inc.’s upcoming earnings report date?
GeneTether Therapeutics, Inc.’s upcoming earnings report date is May 22, 2025 which is 68 days ago.
How were GeneTether Therapeutics, Inc.’s earnings last quarter?
Currently, no data Available
Is GeneTether Therapeutics, Inc. overvalued?
According to Wall Street analysts GeneTether Therapeutics, Inc.’s price is currently Overvalued.
Does GeneTether Therapeutics, Inc. pay dividends?
GeneTether Therapeutics, Inc. does not currently pay dividends.
What is GeneTether Therapeutics, Inc.’s EPS estimate?
GeneTether Therapeutics, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does GeneTether Therapeutics, Inc. have?
GeneTether Therapeutics, Inc. has 75,744,675 shares outstanding.
What happened to GeneTether Therapeutics, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of GeneTether Therapeutics, Inc.?
Currently, no hedge funds are holding shares in TSE:RIZE
Company Description
GeneTether Therapeutics, Inc.
GeneTether Therapeutics, Inc. (RIZE) is a biotechnology company focused on developing innovative gene editing technologies to treat genetic disorders. The company operates in the biotech and healthcare sectors, primarily working on pioneering approaches to enhance the precision and efficiency of gene editing. GeneTether Therapeutics aims to address unmet medical needs by creating therapies that can correct genetic mutations at their source.